Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings will go public soon, but the exact IPO date is still unknown.
Stock Price: $4.50 - $5.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading.
Market Cap | 63.29M |
Revenue (ttm) | n/a |
Net Income (ttm) | -1.81M |
Shares Out | 13.32M |
EPS (ttm) | -0.14 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | n/a |
Open | n/a |
Previous Close | n/a |
Day's Range | n/a |
52-Week Range | n/a |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | n/a |
About SHPH
Shuttle Pharmaceuticals is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT). Although RT is a proven modality for treating cancers, by developing radiation sensitizers, we aim to increase cancer cure rates, prolong patient survival and improve quality of life when used as a primary treatment, or in combination with surgery, chemotherapy and immunotherapy. We currently have no FDA approved products and we have not yet applied for a new drug... [Read more...]
Industry
Health Care
Founded
2012
CEO
Anatoly Dritschilo, M.D.
Employees
5
Stock Exchange
NASDAQ
Ticker Symbol
SHPH
Financial Performance
Financial StatementsNews
Shuttle Pharmaceuticals Holdings IPO Registration Document (S-1)
Shuttle Pharmaceuticals Holdings has filed to go public with an IPO on the NASDAQ